Abstract : The lack of an effective severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) antiviral medication has hindered the response to the coronavirus disease 2019 (C0VID-19) pandemic. A descriptive, observational, cross-sectional research examined a sample of Covid-19 patients with and without Remdesivir in their therapy. In this quantitative study, the utilization of Remdesivir in the treatment of COVID-19 inpatients at Al-Kindy Teaching Hospital was evaluated. Setting location and schedule From 7 January to 15 February 2021. Participants were selected from Al-Kindy Teaching hospital inpatients. There is No significance relationship between gender and age with Remdesivir use. There is no significant relation between Remdesivir use and severity of admission. No significant relation between used Remdesivir and did not use Remdisivir with drugs of HCQ. There is no significant relation between Used Remdisivir and did not use Remdisivir with concomitant diseases. There is no significant relation between Used Remdisivir and did not use Remdisivir with response of treatment. There is no significant relation between Used Remdisivir and did not use Remdisivir with admission to CCU.